Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$353,732
+$181,221 QoQ
Shares Held
46,119
+202.4% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 168 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 94.45347904334439.ToString("F0")%
Shared 0.ToString("F0")%
None 5.546520956655608.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Man Group plc holds $1,080,100,046 across 125 Biotechnology names. FULC ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315,212 | $243,545,399 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
236,798 | $105,739,778 | |
| 3 | INCY |
Incyte Corp
|
930,171 | $87,547,693 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
232,369 | $76,883,931 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
241,922 | $71,843,576 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
915,689 | $36,838,167 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
275,270 | $26,770,006 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
135,212 | $25,561,828 |
All Filings in FULC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $353,732 | 46,119 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $172,511 | 15,253 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $172,516 | 48,324 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $965,013 | 102,226 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $638,664 | 94,617 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $699,986 | 96,152 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $693,782 | 85,758 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $612,147 | 124,928 | Principal | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||